TECX FY 2021 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$16M

Net Income

-$9M

EPS (Diluted)

$-33.36

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$15M

Stock-Based Comp.

$639,000

Balance Sheet

Total Assets

$33M

Total Liabilities

$48M

Stockholders' Equity

-$15M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$16M	-$120M	+87.0%
Net Income	-$9M	-$120M	+92.5%